Research Open Terminal →
IDXX

Idexx Laboratories

XNAS · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

2 articles20 insider tx0 holders0 supply chain6 selling intent filings0 new insiders

Research articles

Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.

View all articles →

Recent insider activity

Insider net $ (monthly)open-market Form 4 only - grants, exercises, tax withholding excluded$50.0M$25.0M$0-$25.0M-$50.0M2024-10 $02024-11 -$145K2024-12 $02025-01 $02025-02 -$6.0M2025-03 $02025-04 $02025-05 -$3.2M2025-06 $02025-07 $02025-08 -$34.3M2025-09 $02025-10 $02025-11 -$6.6M2025-12 $02026-01 $02026-02 -$28.7M2026-03 -$1.1M2026-04 $02026-05 $02026-06 $02026-07 $02026-08 $02026-09 -$1.2M2026-10 $02026-11 -$27.4MOct 24Dec 24Feb 25Apr 25Jun 25Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26Oct 26~ derived from SEC-reported shares x price. Hatched: excluded (implausible price) or unpriced.

open-market Form 4 only - grants, exercises, tax withholding excluded

0 buyers - 5 unique sellers · Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.

Date Insider Title Type Shares Price Value
November 10, 2026 Fennell George Executive Vice President OPTION_EXERCISE -483 — —
November 10, 2026 Fennell George Executive Vice President OPTION_EXERCISE -560 — —
November 10, 2026 Fennell George Executive Vice President OPTION_EXERCISE -706 — —
November 10, 2026 Fennell George Executive Vice President OPTION_EXERCISE 483 $207 ~$100K
November 10, 2026 Fennell George Executive Vice President OPTION_EXERCISE 560 $178 ~$100K
November 10, 2026 Fennell George Executive Vice President OPTION_EXERCISE 706 $142 ~$100K
November 4, 2026 Underberg Sharon E. EVP, GC & Corporate Secretary OPTION_EXERCISE 8,906 $289 ~$2.6M
November 4, 2026 Underberg Sharon E. EVP, GC & Corporate Secretary SELL -6,348 $688 ~$4.4M
November 4, 2026 Underberg Sharon E. EVP, GC & Corporate Secretary SELL -1,503 $689 ~$1.0M
November 4, 2026 Underberg Sharon E. EVP, GC & Corporate Secretary SELL -1,055 $690 ~$0.7M
November 4, 2026 Underberg Sharon E. EVP, GC & Corporate Secretary OPTION_EXERCISE -8,906 — —
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board OPTION_EXERCISE 25,140 $178 ~$4.5M
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board SELL -1,945 $698 ~$1.4M
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board SELL -4,075 $699 ~$2.8M
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board SELL -1,667 $700 ~$1.2M
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board SELL -4,540 $701 ~$3.2M
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board SELL -2,136 $702 ~$1.5M
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board SELL -3,950 $703 ~$2.8M
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board SELL -240 $706 ~$0.2M
November 4, 2026 Mazelsky Jonathan Jay Executive Chair of the Board SELL -840 $707 ~$0.6M

Insider Selling Intent (Form 144)

Date Filer Relationship Est. shares Filing
November 4, 2026 Junius Daniel M — 500 SEC
November 4, 2026 Sharon E Underberg — 8,906 SEC
November 4, 2026 Michael J Lane — 3,979 SEC
November 4, 2026 Jonathan J Mazelsky — 25,140 SEC
September 4, 2026 Lawrence D Kingsley — 2,203 SEC
May 20, 2026 Margaret Anne Szostak — — SEC
Want deeper analysis?
Investabot monitors SEC filings daily and generates institutional-grade research on insider trades, risk factors, supply chains, and more.
Open the Terminal — Free →